MRM Health, a clinical-stage biopharmaceutical company developing microbiome-based therapeutics for inflammatory diseases and ...

Topadur Pharma, a clinical-stage biotechnology company specialising in therapies for vascular regeneration, has announced the ...

“The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated new asset. Pozdeutinurad has ...

BICO has announced the appointment of Jesper Hagberg as its new Chief Operations & Digital Officer.

Lindus Health and Quotient Sciences have announced a strategic partnership to enable enhanced patient recruitment and ...

Xmoor Pharma has established a strategic collaboration with the Translational Research Office (TRO) and University College ...

Title21 Health Solutions, a portfolio company specialising in supporting life science regulatory needs, has joined the Blood ...

Finnish biotechnology company NADMED has announced the launch of the NADMED Award 2026 in the hope of generating new ...

Enterprise Therapeutics has announced the publication of results from its phase 1 study of ETD001, a long-acting inhaled ...

GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic pulmonary ...

Miranda Dini has announced the launch of GOLD Strategy & Communications, a global healthcare consultancy designed to provide ...

Johnson & Johnson has received European Commission approval for nipocalimab, marketed as IMAAVY, as an add-on therapy for generalised myasthenia gravis (gMG).